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Disruption of Axonal Transport and
Neuronal Viability by Amyloid Precursor
Protein Mutations in Drosophila
One possibility for the absence of severe defects in APP
knockout mice is functional redundancy provided by
the amyloid precursor-like proteins APLP1 and APLP2,
which are relatives of APP (Wasco et al., 1993). Support
for this view comes from the observation that double
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APP homologs have been identified in invertebrate
model systems: the amyloid protein-like protein 1
(APL-1) in Caenorhabditis elegans (Daigle and Li, 1993)Summary
and the amyloid precursor protein-like protein (APPL) in
Drosophila melanogaster (Rosen et al., 1989). AlthoughWe tested the hypothesis that amyloid precursor pro-
both of these proteins have sequence similarity to APPtein (APP) and its relatives function as vesicular recep-
throughout their length, both lack similarity within thetor proteins for kinesin-I. Deletion of the Drosophila
A region, which corresponds to the 4Kd proteolyticAPP-like gene (Appl) or overexpression of human
fragments found in amyloid deposits. Similar to theAPP695 or APPL constructs caused axonal transport
mouse APP deletion mutants, flies lacking APPL (Luo etphenotypes similar to kinesin and dynein mutants. Ge-
al., 1992) are viable, fertile, and have a subtle behavioralnetic reduction of kinesin-I expression enhanced while
phenotype that can be rescued by wild-type humangenetic reduction of dynein expression suppressed
APP; a minor decrease in synaptic bouton number wasthese phenotypes. Deletion of the C terminus of APP-
also found (Torroja et al., 1999b).695 or APPL, including the kinesin binding region, dis-
Thus, there is not yet a clear understanding of therupted axonal transport of APP695 and APPL and abol-
normal functions of the APP family of proteins in neu-ished the organelle accumulation phenotype. Neuronal
rons. Current suggestions include a receptor functionapoptosis was induced only by overexpression of con-
for an unknown ligand, roles in neuron viability, antago-structs containing both the C-terminal and A regions
nism of heme oxygenase activity, a role in axonogenesis,of APP695. We discuss the possibility that axonal
copper homeostasis, dendritic arborization, a possibletransport disruption may play a role in the neurodegen-
pro- or antiapoptotic function, roles in cell growth anderative pathology of Alzheimer’s disease.
cell adhesion, and promotion of synaptic differentiation
(reviewed in Takahashi et al., 2000; De Strooper andIntroduction
Annaert, 2000; Torroja et al., 1999b). Recently, biochemi-
cal analyses led to the new proposal that APP has anMutations in the gene encoding the human amyloid pre-
important function as a membrane receptor protein thatcursor protein (APP) cause familial Alzheimer’s disease
links conventional kinesin, kinesin-I, to vesicles moved(FAD), perhaps by altering proteolytic processing or traf-
by the fast anterograde axonal transport machinery (Ka-ficking of APP. Other genes, such as presenilins, which
mal et al., 2000). Consistent with this idea, a previousalso cause FAD when mutant, encode proteins that in-
study reported that overexpression of APPL in neuronsteract with or mediate proteolytic processing of APP. In
disrupts axonal transport. In addition, overexpressionspite of considerable study, however, the normal func-
of Drosophila APPL also causes a cuticle tanning defect
tions of APP remain elusive. Whether the normal function
in eclosed adults that is genetically enhanced by reduc-
of APP has any relationship to the development of Alz-
ing the dosage of kinesin heavy chain (Torroja et al.,
heimer’s disease (AD) is similarly obscure. 1999a).
APP is a conserved type 1 transmembrane protein The hypothesis that APP functions as a vesicular re-
that has a broad tissue distribution, including expression ceptor for kinesin-I is primarily based on in vitro experi-
within neurons. In axons, the majority of APP is trans- ments and is largely untested in vivo. Here, we use
ported in the fast anterograde but not retrograde axonal genetic analysis in Drosophila to test directly a number
transport component (Kamal et al., 2000; Koo et al., of unique in vivo predictions of this hypothesis. We find
1990). APP is also found in neuronal vesicles, neuronal that these in vivo predictions are largely fulfilled, sup-
soma, axons, dendrites, and neuronal surfaces (Capo- porting a function for the APP family of proteins as vesic-
raso et al., 1994). Although these data suggested that ular receptors for kinesin-1. Additionally, we find that
APP would have an essential function, perhaps in neu- neuronal death can be caused by expression of human
rons, mice homozygous for an APP null mutation are APP in Drosophila neurons. APP-induced neuronal
viable and fertile (Zheng et al., 1995). They also have death exhibits striking and consistent genetic interac-
clear but limited locomotor, behavioral, and cellular de- tions with the molecular motor machinery, suggesting
fects (Zheng et al., 1995; Magara et al., 1999; Dawson a direct link between the induction of neuronal death
et al., 1999; Seabrook et al., 1999). In addition, trans- by APP and its function as a kinesin-I receptor.
genic mice that overexpress various forms of APP have
increased levels of amyloid  (A) deposits but still sur- Results
vive well into adulthood (reviewed in Price et al., 1998).
The hypothesis that APP functions as a vesicular recep-
tor for kinesin-I makes a number of unique in vivo predic-1Correspondence: lgoldstein@ucsd.edu
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Figure 1. Axonal Transport Defects in the Appl Deletion
(A) Immunostaining of larval segmental nerves with the synaptic vesicle marker SYT, from wild-type, dhc/ (dhc6-10 ), and Appl/. Note organelle
accumulations within larval neurons from Appl/ and dhc/ (arrows). In contrast, neurons from wild-type larvae stained smoothly. Scale bar 
10 m.
(B) Quantitation of organelle jams in Appl/, dhc/, khc/.
tions that are not predicted by any other proposal for trol lines stained only faintly and uniformly. Thus, the
cellular loss of function phenotype of APPL is similar toAPP function. First, loss of APPL should give rise to an
axonal transport phenotype. Second, overexpression of known axonal transport mutants in Drosophila.
Surprisingly, while Appl deletion larvae contain axonalAPP or APPL should also give rise to an axonal transport
phenotype by titrating kinesin-I away from other axonal organelle jams, they are viable and do not exhibit tail
flipping or paralysis. It is conceivable that the extent ofcargoes. Third, phenotypes induced by overexpression
of APP or APPL should depend upon the presence of axonal accumulations determines phenotypic severity.
To evaluate this notion, we quantified axonal accumula-the cytoplasmic domain of APP or APPL, which contains
the proposed kinesin-I binding region. Fourth, pheno- tions (Figure 1B). We found that Appl deletion larvae
had fewer axonal organelle jams than homozygous mu-types induced by overexpression of APP family mem-
bers should be enhanced by genetic reduction of tations lacking kinesin-1 and dynein subunits, which
cause lethality and severe posterior paralysis. Thus, thekinesin-I. Fifth, phenotypes induced by overexpression
of APP family members should be suppressed by ge- extent of blockage within axons may determine the se-
verity of the organismal phenotype.netic reduction of cytoplasmic dynein. We describe be-
low the results of testing each of these predictions.
Targeted Overexpression of APPL and Human
APP Causes Axonal Vesicle AccumulationsDeletion of APPL Causes Phenotypes Characteristic
of Axonal Transport Mutants Overexpression of APP, APPL, or any other APP family
member is predicted to cause axonal accumulationsDeletion of Appl (located on the X chromosome) is pre-
dicted to cause defects in axonal transport that manifest that are phenotypically similar to those caused by loss
of APPL function but by a different mechanism. Thisas axonal accumulations of transported components.
This prediction is based on previous work in Drosophila prediction is based on previous work in Drosophila and
mammals that strongly suggests the existence of multi-(Bowman et al., 1999; Gindhart et al., 1998; Hurd and
Saxton, 1996; Martin et al., 1999), which revealed that ple kinesin-I cargoes and pathways (Tanaka et al., 1998;
Swanson et al., 1992; and reviewed in Goldstein, 2001),mutations removing critical components of the axonal
transport machinery exhibited a common neuromuscu- each of which appears to have its own kinesin-I receptor.
Thus, overexpression of one kinesin-I receptor such aslar phenotype including paralysis, narrowing and slug-
gishness in the posterior region of the animal, and “flip- APP or APPL is expected to compete for kinesin-I with
these other pathways, leading to stalling of a differentping” of the tail during crawling. In addition, maternally
provided motor protein or attendant functions needed class of organelle or vesicle than the type defined by
APP or APPL but nonetheless causing a common axonalfor proper movement become depleted during neuronal
development, leading to vesicle or organelle stalling and blockage phenotype.
To test this prediction, we studied a number of differ-apparent axonal blockages or “organelle jams.” This
phenotype is particularly severe in the long narrow ax- ent APPL and human APP proteins (Figure 2A). We used
the GAL4-UAS system in which expression is inducedons of the peripheral nervous system of the third instar
larva. by combining transgenes under the control of UAS se-
quences with GAL4 transgenes known to have neuronalTo test the prediction that deletion of Appl will cause
defects in axonal transport, we immunostained neurons expression patterns. We used two GAL4 lines, Appl-
GAL4 (Torroja et al., 1999b) and 179y-GAL4 (Blooming-of mutant and wild-type larvae with antibodies against
the synaptic vesicle markers cysteine string protein ton), both located on the X chromosome, both with
neuronal expression patterns. We confirmed their ex-(CSP) and synaptotagmin (SYT). We observed numerous
accumulations in axons from Appl deletion larvae (Fig- pression patterns by crossing these lines to UAS-GFP
(Brand, 1995).ure 1A). As is typical of wild-type, larval neurons in con-
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Figure 2. Overexpression of APP and APPL Cause Organelle Jams in a C-Terminal-Dependent Manner
(A) Constructs used in overexpression analysis. A region is indicated by the black box. “TM” represents the transmembrane region. “SP”
represents the signal peptide. 695delCT has the entire C-terminal region of APP deleted. The amino acid changes in the SWE and LOND
mutations are indicated as *. The short COOH fragment is named “SPA4CT.” The chimeric protein 695APLP2 has the A region and the entire
C-terminal region of APP695 replaced by the homologous region of human APLP2. For APPL, “E” indicates the conserved extracellular domain,
and “C” indicates a possible cleavage site. APPLS is the secreted form. APPLSD has the cleavage site deleted, and APPLdelCT has the entire
C terminus of APPL deleted.
(B) Immunostaining of larval neurons with SYT shows organelle jams (arrows) in APP695, SWE, 695APLP2, SPA4ACT, LOND, APPLSD, and
APPL but not in 695delCT, APPLS, and APPLdelCT. Scale bar  10 m.
(C) Quantitative analysis of organelle jams.
(D) Western analysis of transgenic protein expression.
Overexpression of APPL and APP695 caused similar 2D), it is unlikely that this effect is due to dosage com-
pensation, since no sex-specific effect was observedphenotypes when expression was induced by either of
the two GAL4 lines. Immunostaining with SYT and CSP for APPL or other mutants. It is possible that the chromo-
somal position of the APP695 transgene affects expres-antibodies showed numerous organelle accumulations
within larval axons, similar to APPL deletion and axonal sion due to a nearby male-specific enhancer.
transport mutants (Figure 2B). Quantitative analysis re-
vealed no significant differences between the two GAL4 Organelle Jams and Entry of APP into Axons
Depend upon the APP C Terminuslines (data not shown). Protein expression of human
APP proteins induced by these two GAL4 lines was Axonal blockages caused by overexpression of APP
family members should require the conserved cyto-found to be relatively similar.
While most lines showed no difference between males plasmic C terminus of these proteins, which contains the
kinesin-I binding region. In the absence of this region,and females, we did observe a difference in frequency
of axonal accumulations in male versus female larvae kinesin-I should not be titrated away from other trans-
port pathways. To test this prediction, we utilized mutantexpressing APP695 (p  0.001) (Figure 2C). These male
larvae also fail to develop to adulthood. Although some constructs of APP695 and APPL (Figure 2A). We exam-
ined the Swedish mutant (SWE), the London mutantdifference in protein expression was observed (Figure
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(LOND), a COOH terminal fragment of APP695 that lacks such a reduction in an animal overexpressing APP pro-
teins that contain the cytoplasmic C terminus is pre-the bulk of the extracellular domain (SPA4CT), and a
dicted to significantly enhance the axonal blockage phe-deletion of the cytoplasmic C terminus of APP695
notype. This behavior is expected, because if kinesin-I(695delCT). In addition, we evaluated a chimeric protein,
becomes limiting by virtue of binding excess APP CAPP695-APLP2 (695APLP2), which has the A region
termini, then further reduction of kinesin-I by deletingand the entire C terminus of APP695 replaced by the
one gene copy should dramatically enhance the axonalhomologous region of the APP relative APLP2 (Foss-
transport phenotype. To test this prediction, we gener-green et al., 1998). Quantitative analysis revealed that
ated larvae that overexpressed APPL or APP695 andthe SWE and LOND mutants had numerous organelle
that were also heterozygous for a null mutation, khc8jams, while SPA4CT caused somewhat less (Figures 2B
(Hurd and Saxton, 1996), so that kinesin-I was reducedand 2C). The other lines were intermediate in severity,
to 50% of normal. Although larvae overexpressing APPLwith 695APLP2 and APPL exhibiting similar numbers of
or APP by themselves or reduced in KHC dosage aloneaccumulations.
had no striking organismal phenotype, larvae combiningWe also did not see any sex-specific effects, although
these two features exhibited a dramatic new neuromus-there were minor differences in protein expression (Fig-
cular phenotype. These larvae flipped their tail and headure 2D). Strikingly, deletion of the C terminus in 695delCT
upwards during crawling, rocking back and forth as theycompletely abolished the formation of organelle accu-
struggled to crawl. Their neurons also contained an en-mulations and only showed diffuse staining similar to
hanced number of organelle accumulations (Figure 4A).wild-type. Thus, formation of axonal accumulations is
The extent of accumulations in larvae expressing wild-dependent upon the C terminus of APP.
type APP695 and APPL in the context of reduced KHCPreviously, the cytoplasmic domain of APPL was re-
dosage was comparable to homozygotes for kinesin-Iported to be required for induction of synaptic differenti-
or dynein mutants and was similarly lethal. Siblings fromation at neuromuscular junctions (Torroja et al., 1999b).
these crosses that had normal KHC levels were found toTo investigate if the APPL C terminus is also necessary
show the same extent of accumulations as our previousfor the formation of axonal aggregations, we examined
results. Quantitative analysis revealed a statistically sig-several APPL derivatives (Torroja et al., 1999b; Figure
nificant difference (p  0.001) between siblings with a2A). We expressed the secreted form, APPLS lacking
normal and reduced dose of KHC (Figure 4A).the transmembrane and cytoplasmic domains of APPL,
Confirmation of the specificity of this enhancementAPPLSD lacking the proteolytic cleavage site, and
came from control animals in which Appl-GAL4 wasAPPLdelCT, which lacks the entire C terminus of APPL.
combined with a heterozygous khc mutant in the ab-We found no axonal accumulations in larvae overex-
sence of an APPL or APP transgene. Few or no organellepressing APPLS or APPLdelCT, consistent with our re-
accumulations were observed in these animals or insult for 695delCT (Figure 2B). Organelle accumulations
simple khc heterozygotes (Figure 4A). In addition, nowere observed in APPLSD, a secretion-defective mem-
enhancement and genetic interaction was seen whenbrane-bound form that still retains the C terminus.
overexpression of 695delCT or APPLdelCT was com-Immunostaining with antibodies specific to APP (4G8)
bined with the heterozygous khc deletion (Figure 4A).and SYT revealed APP staining within larval neurons
This result is consistent with a direct functional interac-and in axonal accumulations in larvae expressing
tion of the C-terminal region of APP and APPL withAPP695, the SWE and LOND mutants, and SPA4CT
kinesin-I.transgenic lines (Figure 3A). As expected, APP staining
To confirm the specificity of the genetic interactionsby 4G8 was not observed in 695APLP2, since the region
observed between reduction in KHC and overexpres-bearing the 4G8 epitope is missing in this hybrid protein;
sion of APP695 or APPL, we also generated larvae het-this result establishes the specificity of 4G8 staining
erozygous for a null mutation of klc [Df(3L)8ex94, which
in this system. Strikingly, little staining within axons of
removes the entire kinesin light chain gene; Gindhart
695delCT was observed, although prominent punctate
et al., 1998] in combination with constructs expressing
staining was observed within these larval brains (Figure APPL and APP695. Neurons from these larvae contained
5A). This finding is consistent with the comparable ex- an increased number of organelle jams relative to larvae
pression of 695delCT to other constructs (Figure 2D). with a normal dose of KLC. Quantitative analysis re-
Thus, the failure of the C-terminal deletion of APP to vealed a statistically significant difference between sib-
induce organelle jams is not a result of an expression lings containing a normal and reduced dose of KLC (p
failure, and the C terminus of APP may be necessary for 0.05) (Figure 4B), although the extent of enhancement
axonal entry. Consistent with this view, neuromuscular was not as dramatic as when the dosage of KHC was
junction staining of APP is observed in APP695, SWE reduced. Although these larvae did not show a larval
and LOND mutants, and SPA4CT but not in 695delCT neuromuscular phenotype as dramatic as was observed
(Figure 3B), suggesting that the truncated C-terminal when the dosage of KHC was reduced, these larvae did
deletion protein is not transported. show a clear posterior paralysis phenotype. As in the
KHC experiments, confirmation of the specificity of the
Axonal Accumulations Caused by Overexpression effect came from control animals in which Appl-GAL4
of APP or APPL Are Enhanced by Genetic was combined with a heterozygous klc mutant in the
Reduction of Kinesin-I absence of an APPL or APP695 transgene. Effectively,
Although reducing the amount of kinesin-I to 50% of no organelle accumulations were observed in these ani-
normal by deleting one of two copies of either the klc mals or in simple klc heterozygotes (Figure 4B). In addi-
tion, no enhancement was seen when 695delCT oror khc gene ordinarily has no significant phenotype,
The Role of APP in Kinesin-I-Dependent Transport
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Figure 3. Entry of APP into Axons and Transport of APP Is Dependent upon the C Terminus
(A) APP (4G8 staining, left) is observed within axons and within organelle accumulations in APP695, SWE, SPA4CT, and LOND. Little or no
4G8 staining is observed in 695delCT. 695APLP2 acts as a control, as it lacks the 4G8 epitope. SYT is center and merged (right). Scale bar 
10 m.
(B) APP (4G8 staining, left) is observed within neuromuscular junctions of APP695, SWE, SPA4CT, and LOND. Note that no 4G8 staining is
observed in 695delCT neuromuscular junctions. Scale bar  10 m.
APPLdelCT were combined with the heterozygous klc to or somewhat less than was observed for mutant Appl
homozygous larvae.deletion. This result is again consistent with a direct
functional interaction of the C-terminal region of APP695
and APPL with kinesin-I. Axonal Accumulations Caused by Overexpression
of APP or APPL Are Suppressed by GeneticFinally, we investigated whether larvae bearing het-
erozygous deletions of kinesin components and Appl in Reduction of Dynein
Although reducing the amount of cytoplasmic dynein tocombination would exhibit abnormal axonal transport.
We found that female larvae with one copy (50% dose) 50% of normal by deleting one of two copies of either
dynein heavy chain (dhc) or dynein light chain (dlc) genesof Appl and one copy of a functional khc or klc gene
had typical axonal accumulations (data not shown). Male ordinarily has no significant phenotype, such a reduction
in an animal overexpressing APP family members thatlarvae bearing a deletion of Appl, and hence lacking all
APPL function, in combination with one copy of khc contain the cytoplasmic C terminus is predicted to sup-
press significantly the severity of the axonal accumula-or klc also had axonal accumulations. The extent of
accumulations in these combinations was comparable tion phenotype. The basis for this prediction is that dy-
Neuron
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Figure 4. Reduction of Kinesin-I Enhances the Organelle Jam Phenotype in a C-Terminal-Dependent Manner While Reduction of Dynein
Suppresses the Organelle Jam Phenotype
(A and B) Quantitative analysis of genetic interactions with KHC (A) and KLC (B) reduction.
(C and D) Quantitative analysis of genetic interactions with DLC (C) or DHC (D) reduction.
nein drives retrograde axonal transport, which is antago- was seen in the lines expressing a C-terminal deletion
of APP695 or APPL. Thus, reduction in dosage of anistic to kinesin-I-mediated anterograde axonal trans-
port. In addition, many vesicles or organelles that exhibit retrograde motor protein appears to be sufficient to
decrease organelle accumulations induced by APP ornet anterograde movement experience periods of retro-
grade movement owing to the simultaneous presence APPL expression.
Finally, we investigated whether larvae bearing het-of kinesins and dyneins on the same vesicle or organelle
(e.g., Kaether et al., 2000; Reese and Haimo, 2000). Thus, erozygous deletions of dynein components and the Appl
gene in combination would exhibit abnormal axonalvesicle stalling and axonal accumulations induced by
APP are predicted to be ameliorated by dynein reduction transport. In contrast to the situation with kinesin and
APPL, we found that female larvae with one copy (50%by (1) reducing the rate at which vesicles and organelles
moved by dynein are transported into regions that have dose) of Appl and one copy of dhc or dlc did not have
typical axonal accumulations (data not shown). Intrigu-stalled or accumulated vesicles caused by APP expres-
sion; or (2) Reducing the contribution of dynein-driven ingly, male larvae bearing a deletion of the Appl gene,
and hence lacking all APPL function, in combinationmovement to a vesicle experiencing stalling because of
reduced kinesin-driven activity; this reduction should with one copy of dhc or dlc also lacked axonal accumu-
lations. Thus, reduction in dynein levels appears to sup-attenuate vesicle stalling by restoring the balance of
movements toward normal. press axonal accumulations induced by loss of APPL.
To test this prediction, we generated larvae overex-
pressing APP695 or APPL that were also heterozygous Overexpression of APP Causes
Neuronal Apoptosisfor a deficiency of dhc [Df(3L)GN24] or dlc (roblk; Bow-
man et al., 1999). We observed that reduction of dynein Programmed cell death, neuronal loss, and A aggrega-
tion are regularly detected in the brains of human ADsuppressed the extent of organelle accumulations in
APP695 or APPL transgenic lines (p  0.001) (Figures patients (Citron et al., 1992) and in some transgenic
mouse models of AD (Moechars et al., 1999; Masliah et4C and 4D). In addition, no significant larval crawling
phenotype was observed in these animals. To our sur- al., 1996). However, the relationship between APP, A,
apoptosis, and the neurodegenerative mechanism is un-prise, reduction in dynein dosage also rescued the invia-
bility of males overexpressing APP695. Again, no effect known. To investigate if overexpression of APP leads
The Role of APP in Kinesin-I-Dependent Transport
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Figure 5. Neuronal Apoptosis Visualized by TUNEL Staining Is Induced by APP Expression and Shows Genetic Interactions with Reduction
of Kinesin and Dynein
(A) Neuronal cell death is induced by APP695, SWE, and SPA4CT but not 695delCT and 695APLP2. APP accumulations are also observed
within the cytoplasm of neuronal cells in APP695, SWE, and SPA4CT, while punctate staining is observed in 695delCT. Scale bar  10 m.
(B–E) Quantitative analysis of TUNEL staining shows the extent of neuronal cell death enhanced by the reduction of KHC (B) and KLC (C) and
suppressed by the reduction of DIC (D) and DHC (E).
to neuronal cell death in Drosophila, we tested for apo- 1996; Moechars et al., 1999), we found elevated neuronal
death in SWE and LOND mutants relative to APP695. Inptosis by TUNEL staining of larval brains. Increased cell
death was observed in larval brains of transgenic lines addition, we found that neuronal cell death was in-
creased in APP695, SWE, LOND, and SPA4CT when theexpressing APP695, SWE and LOND mutants, and
SPA4CT (Figure 5A). No cell death was caused by dose of KHC or KLC was reduced (Figures 5B and 5C).
No induction of neuronal cell death was seen when KHC695delCT. Strikingly, no neuronal death was seen in
APPL deletion larvae or larvae overexpressing any APPL or KLC dosage was reduced in combination with expres-
sion of 695APLP2 or APPL, suggesting that the nonho-transgene (data not shown). 695APLP2 also did not
show TUNEL-positive cells even though it had substan- mologous A region may be required for neuronal death.
Strikingly, neuronal cell death was abolished in APP695,tial organelle accumulations. We also found that simple
perturbation of axonal transport does not cause cell SWE, LOND, and SPA4CT when the dose of DHC and
DLC was reduced (Figures 5D and 5E), indicating thatdeath, as larvae homozygous for dynein or kinesin-I
mutants showed no neuronal death at this larval stage reducing a retrograde motor protein is sufficient to de-
crease neuronal cell death induced by APP.(data not shown). Excess protein expression also ap-
peared not to cause neuronal death, since similar protein To determine if excess APP accumulated within neu-
ronal cells, we also stained these larval brains with anexpression was observed in 695delCT and 695APLP2
animals (Figure 2D). APP antibody (4G8). We found uniform cytoplasmic 4G8
staining in neuronal cells of larvae expressing APP695,It is intriguing that apoptosis was only observed in
lines expressing proteins containing both the A region the SWE mutant, and SPA4CT, while punctate cyto-
plasmic staining was observed in brains expressingand the cytoplasmic C terminus, which appears to be
essential to induce axonal accumulations. Consistent 695delCT (Figure 5A). Accumulation of APP was also
observed within neuronal cells that contain TUNEL-posi-with the observation that SWE and LOND mutants cause
FAD and that human AD brains and mouse models con- tive nuclei.
To determine if presence of the A region of APP intaining SWE and LOND mutations show increased levels
of A accumulation (Gervais et al., 1999; Masliah et al., neurons having organelle accumulations was sufficient
Neuron
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to induce neuronal death, we combined two different biochemical evidence for a kinesin-I receptor function
for APP. In these experiments, APP was shown to formconstructs. One construct we expressed was 695delCT,
a complex with conventional kinesin by directly bindingwhich has an A region but lacks the cytoplasmic C
to KLC (Kamal et al., 2000). This and other previousterminus and hence does not induce axonal accumula-
studies also showed that transport of APP dependedtions. The other construct we expressed was 695APLP2,
upon kinesin-I and KLC in particular (Ferreira et al., 1992;which lacks an A region but has the conserved cyto-
Kaether et al., 2000). In addition, our finding that, inplasmic C terminus and so induces axonal accumula-
Drosophila, APP695 can enter and be transported downtions but not neuronal death. We found that larvae
axons to neuromuscular junctions and that this transportexpressing both of these constructs had axonal accu-
depends upon the cytoplasmic C terminus containingmulations but not neuronal death; the axonal accumula-
the proposed KLC binding region supports this view.tions did not stain with 4G8 (data not shown), confirming
It is puzzling that analogous experiments using APPthat 695delCT could not be transported into axons.
overexpressed in cultured hippocampal neurons fromThus, addition of a protein containing an A region to a
Semliki Forest Virus (SFV) vectors did not identify a re-cell with axonal accumulations is not sufficient to induce
quirement for the C terminus for axonal entry (Tienari etneuronal death.
al., 1996). Whether these differences reflect differencesFor more information, see the Supplemental Data at
in cell types or an anomaly of the very high level ofhttp://www.neuron.org/cgi/content/full/32/3/389/DC1.
overexpression from SFV is unknown. Nonetheless, in
toto, these data strongly support the hypothesis thatDiscussion
APP functions as a kinesin-I receptor. Perhaps APP
bound to kinesin-I may be required for the axonal trans-Do APP and APP-like Proteins Function
port of a subset of cargoes, such as vesicles containingas Receptors for Kinesin-I?
signaling or other molecules used at the synapse. Identi-Our genetic analysis in Drosophila strongly supports
fying these vesicles and their cargoes is an importantthe hypothesis that APP and its homolog, APPL, have
next step.kinesin-I receptor functions in vivo. This conclusion is
A surprising finding from our studies is the suppres-supported by several genetic behaviors that confirm
sion of APP and APPL-induced organelle accumulationsunique predictions of this hypothesis. First, loss of APPL
by genetic reduction of cytoplasmic dynein (Figure 6A).causes an axonal transport phenotype similar to that
Although further work is needed to define the mecha-seen in kinesin and dynein mutants. Second, overex-
nism of this suppression, one simple explanation comespression of APPL and APP also cause an axonal trans-
from previous observations about the functionally an-port phenotype. Third, organelle accumulation pheno-
tagonistic relationship of dynein and kinesin. A generaltypes induced by APP or APPL overexpression are
observation (Kaether et al., 2000; Reese and Haimo,dependent upon the cytoplasmic C terminus that con-
2000; reviewed in Goldstein and Yang, 2000) is thattains the proposed kinesin-I binding region. Fourth, axo-
kinesin and dynein are both present on many of thenal phenotypes induced by excess APP or APPL are
same axonal vesicles and organelles. Such vesicles and
enhanced by genetic reduction of kinesin-I and sup-
organelles often exhibit alternating anterograde (kinesin)
pressed by the reduction of cytoplasmic dynein, in a C
and retrograde (dynein) movements, with net antero-
terminus-dependent manner. Thus, these data provide
grade or retrograde movement resulting from a regu-
strong in vivo support for the proposal that APP and lated bias in the balance of opposing movements along
APP-like proteins function as membrane-associated re- the microtubule. Thus, reduction of kinesin-I on non-
ceptors for the axonal transport of a subclass of vesicles APP vesicles caused by binding of kinesin-I to excess
by direct interaction with kinesin-1 in vivo. APP might cause vesicle stalling and organelle accu-
It is important to our interpretation that the overex- mulations. Stalling of these vesicles and subsequent
pression or loss of most proteins does not lead to axonal phenotypes might be rescued by reducing the antago-
aggregations characteristic of axonal transport defects. nistic component of movement produced by dynein (Fig-
Overexpression of UAS-GFP did not show axonal accu- ure 6B).
mulations nor did overexpression of several APP or An important related question is whether APP and
APPL proteins lacking the C-terminal cytoplasmic do- APPL have functions in addition to their likely roles as
main. Similarly, a recent screen we carried out of 3572 kinesin-I receptors on vesicles. Thus, one extreme pos-
P element lines identified just nine genes showing both sibility is that all phenotypic effects caused by genetic
larval motility and organelle clogging phenotypes char- manipulation of APPL or APP result from either titration
acteristic of axonal transport mutants. Finally, of all of available kinesin-I or failure to deliver other compo-
known genes that cause the organelle jam phenotype nents of vesicles whose movement depends upon APP
when mutant, seven of eight discovered thus far encode or APPL. However, a number of observations support
subunits of kinesin-I, cytoplasmic dynein, dynactin, or the view that APP and APPL may have additional func-
the dynein-associated LIS-1 complex (Liu et al., 2000). tions, perhaps mediated by the extracellular domain of
The single exception (other than APPL) encodes a pro- the protein. For example, the secreted form of APP has
tein likely to have a kinesin-I receptor function (sunday been implicated in the regulation of haemostasis and
driver, Bowman et al., 2000). These data suggest that neuroprotection, while the intact molecule may be in-
the axonal accumulation phenotype caused by APP and volved in cell-extracellular matrix adhesion and in the
APPL expression is relatively rare and specific to pro- sequestration of potentially toxic transition metals (re-
teins with axonal transport functions. viewed in Storey and Cappai, 1999). There is also evi-
dence that APPL may have a role in synapse differentia-Our genetic data and tests complement the in vitro
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Figure 6. Summary of Results and Model for
How Excess APP (and APP-like Proteins)
Cause Axonal Transport Defects and Neu-
ronal Death
(A) Summary of axonal transport defects
(“JAMS”) and neuronal cell death observed
for APP and APP-like constructs.
(B) Model for the enhancement and suppres-
sion of axonal transport and neuronal death
phenotypes by the reduction of kinesin-I and
dynein. In wild-type (I), active kinesin and
dynein are both present on APP and non-APP
vesicles moving in the anterograde direction.
(II) When APP is in excess, kinesin-I binds
excess APP, thus titrating kinesin-I from non-
APP vesicles, causing non-APP vesicles to
stall and inducing a retrograde death signal
if an A-containing region is in the organelle
jam. (III) When kinesin is reduced in the pres-
ence of excess APP, vesicle stalling and
death are enhanced because of further re-
duction in functional kinesin-I on non-APP
vesicles. (IV) When dynein is reduced in the
presence of excess APP, transport is re-
stored to normal because retrograde force is
reduced.
tion (Torroja et al., 1999b). Thus, APPL and APP may ing to the transmembrane proteins ApoER2, Megalin, or
LRP (Gotthardt et al., 2000; Stockinger et al., 2000; Ver-have additional roles at the nerve terminal following their
role in the axon as receptors for kinesin-I-dependent hey et al., 2001). Consistent with the view that APPL
mediates a minor pathway is the observation that whiletransport.
One perplexing aspect of our and others’ data on APP loss of APPL causes obvious organelle jams, their fre-
quency is considerably less than in kinesin or dyneinand APPL is that deletions of APP and Appl are viable.
However, some but not all workers have reported defi- mutants that presumably block all such pathways. In
fact, our quantitative analysis indicates an obvious cor-cits in behavior, LTP, synaptic plasticity, and synaptic
immunoreactivity, as well as defects in the corpus cal- relation between the extent of axonal accumulations
and viability. Our data are consistent with transgeniclossum and neuromuscular ability caused by APP dele-
tions in the mouse (Magara et al., 1999; Seabrook et al., mouse models of APP, which, despite high levels of
neuronal APP expression, live well into adulthood (Bux-1999; Dawson et al., 1999; Luo et al., 1992; Zheng et al.,
1995; Heber et al., 2000). These phenotypes could be baum et al., 1993; Hsiao et al., 1996). To our knowledge,
these animals have not been tested for reduction incaused by the reduction in APP-dependent axonal
transport pathways. An explanation for the viability of kinesin-I-mediated axonal transport. Finally, the APP
relatives APLP1 and APLP2 may also provide vesicularAPP and Appl deletions is provided by the possibility
that there may be several independent kinesin-I-driven receptor functions in mammalian axons. Indeed, evi-
dence for functional redundancy comes from the obser-vesicular axonal transport pathways in Drosophila and
mammals, only one of which is dependent upon APP or vation that, while all single deletion mutants of these
genes are viable in the mouse, some double mutantAPPL. Consistent with this view is the recent report
of other proteins apparently linking kinesin-I to axonal combinations are inviable (Heber et al., 2000).
vesicles. One such protein is encoded by the sunday
driver (syd) gene in Drosophila, which is the homolog of Axonal Transport and Alzheimer’s Disease
Alzheimer’s disease is a progressive neurodegenerativemammalian JIP-3, a scaffold protein for signaling com-
ponents of the JNK pathway (Bowman et al., 2000; Ver- disease characterized by the accumulation of the 4Kd
A proteolytic fragment of APP in amyloid plaques, ag-hey et al., 2001). Another such protein is JIP-1/2, an
unrelated protein that also serves as a scaffold for sig- gregation of phosphorylated tau in neurofibrillary tan-
gles, and massive neuronal death. Amyloid plaques arenaling components of the JNK pathway as well as bind-
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one of the earliest pathological changes observed in the axonal transport machinery. For example, axonal trans-
brains of individuals with AD and in patients with Down’s port defects are observed in transgenic mice expressing
syndrome. In fact, since the gene encoding APP is on human ApoE4, a gene whose allelic state is associated
chromosome 21, trisomy 21 individuals may be analo- with increased risk of AD. In the axonal blockages found
gous to Drosophila overexpressing APP695. To explore in these animals, accumulations of synaptophysin, neu-
whether Drosophila is a useful model to understand rofilaments, mitochrondria, and vesicles are seen (Tes-
some aspects of AD pathology, we asked if larval brains seur et al., 2000). Similarly, overexpression of tau pro-
overexpressing human and Drosophila APP transgenes tein, a major component of neurofibillary tangles, has
exhibited neuronal death. Strikingly, we found neuronal been proposed to inhibit kinesin-I-dependent trafficking
death only in animals overexpressing APP695 con- of vesicles, mitochondria, and endoplasmic reticulum
taining both the A region and the cytoplasmic C-termi- in cultured cells (Ebneth et al., 1998) and the PNS of
nal region. transgenic mice (Galvin et al., 2000). It is also striking that
Quantitative analysis revealed a greater amount of JIP-1/2 proteins, which are scaffolds for components of
neuronal death caused by SWE and LOND mutants, a JNK signaling pathways, may link kinesin-I to ApoER2
result consistent with mouse models of FAD (Gervais et and LRP, which are receptor proteins for ApoE. The
al., 1999; Masliah et al., 1996; Moechars et al., 1999). It allelic state of LRP itself has also been reported to be
is striking that overexpression of APPL or its mutant a predisposing factor for AD (Kang et al., 1997). Thus,
derivatives, 695APLP2, or constructs lacking the cyto- it is conceivable that not only motor proteins but their
plasmic C terminus of APP do not cause neuronal death. cargoes and receptors, such as APP, ApoE, and perhaps
In addition, simple perturbation of axonal transport does secretases and other signaling molecules, coaccumu-
not cause neuronal death, since kinesin, dynein, and late when axonal transport is impaired in any way. Accu-
Appl deletion mutants do not exhibit such death. Al- mulating these proteins together at the same site, at
though the observation that 695APLP2, which contains the same time, may by itself be neurotoxic, may cause
the cytoplasmic region of APLP2, does not induce neu- induction of cellular suicide signals, may block neuro-
ronal death is formally consistent with the possibility trophic and other signaling needed for neuronal viability,
that the cytoplasmic C terminus of APP is required to or may lead to biochemical changes causing excess
induce neuronal death (Lu et al., 2000), we think this production of A, any or all of which may lead to cell
possibility is unlikely in view of the substantial sequence death. Whether these correlations are unrelated or truly
similarity between APP and APLP2 in this region (32/47 indicative of a causative link remains to be tested.
identical; 40/47 similar). Instead, we propose that two Finally, our work and the work of others demonstrates
important requirements for the induction of neuronal that Drosophila is a powerful model organism to study
death in this system are (1) the presence of an A do- neurodegenerative diseases. Drosophila has been used
main; and (2) axonal organelle and vesicle accumula- as a model system for Parkinson’s disease (Feany and
tions. Genetic manipulations that increase the frequency Bender, 2000), Huntington’s disease (Jackson et al.,
of axonal accumulations caused by a protein containing 1998), Spinocerebellar ataxia type 1 (Fernandez-Funez
an A domain increase neuronal death, while genetic et al., 2000; Warrick et al., 1998), and now Alzheimer’s
manipulations that reduce axonal accumulations reduce disease (Wittmann et al., 2001). In this context, an intri-
neuronal death (Figure 6A). Although we cannot rule guing finding is that reduction of cytoplasmic dynein
out the possibility that these manipulations change the dosage suppresses the frequency of axonal accumula-
amounts of APP protein in larval neurons or that neu- tions and neuronal death caused by overexpressing hu-
ronal death and axonal transport defects are unrelated, man APP. These data raise the possibility that genes
the simplest explanation is that transport problems and that enhance or suppress neuronal death caused by
induction of neuronal death are functionally intertwined. overexpression of APP may be easily found using Dro-
While the mechanism of APP-induced neuronal death
sophila genetics. Thus, this system could provide impor-
is not yet clear, the observation that neuronal death can
tant clues for understanding AD.
be linked to perturbation of the axonal transport system
provides evidence that APP-induced neurodegenera- Experimental Procedures
tion may be related to a normal function of APP and
APP-like proteins. Perhaps neuronal death is induced Drosophila Stocks
by cleavage of APP controlled by the A sequence in The Drosophila Appl deletion, UAS-Appl, UAS-Applsd, UAS-Appls,
and UAS-Appldelct lines were obtained from Dr. Kalpana Whiteaxonal blockages or by generation of A itself in axonal
(Brandeis University). The UAS-695, UAS-SWE, UAS-SPA4CT, UAS-blockages. This view requires that Drosophila have se-
695APLP2, and UAS-695DELCT lines were obtained from Dr. Renatocretases, which appears to be correct. Drosophila has
Paro (University of Heidlberg). PCR and sequence analysis were
presenilin and nicastrin genes, suggesting the presence used to reconfirm the identity of all lines. Expression of transgenes
of  secretase activity (Ye et al., 1999; Yu et al., 2000). were induced by Appl-GAL4 (Torroja et al., 1999b) and 179y-GAL4
Although a true homolog of BACE has yet to be identi- (Bloomington) at 29C. Control crosses were performed using Ore-
fied, Drosophila has several aspartyl proteases that gon-R. The neuronal expression pattern of the two GAL4 lines was
determined by crossing to UAS-GFP and observing whole-mountmight be capable of carrying out the  secretase cleav-
larvae by confocal microscopy. Since no significant difference inage. Indeed, it was recently reported that the SPA4CT
phenotype was observed between the two GAL4 lines, Appl-GAL4fragment can be processed to a peptide species thought
only was used for genetic interaction crosses. The plasmid pBS-
to be A in cultured Drosophila cells (Fossgreen et al., 770 containing the 717V→F LOND mutation was a gift from Dr.
1998). Eliezer Masliah (UCSD). pBS-770 was digested with NotI and XbaI
It is also striking that several other proteins thought and cloned into the NotI and XbaI sites of the pUAST vector. The
orientation and identity were checked by restriction enzyme, PCR,to play a role in AD have recently been linked to the
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and sequence analysis. P element-mediated germline transforma- lines; Dr. Eliezer Masliah for the V717F plasmid; and Robert Laymon,
tions were performed, using yw as the parental strain. Two lines Cheryl Herrera, Brady Culver, and Sam Farlow for technical assis-
(V717 line 1 and V717 line 4) were used, with no significant difference. tance. Antibody against Drosophila SYT and CSP were generous
For genetic interaction experiments, Appl-GAL4;T(2:3) CyO TM6B, gifts from Drs. Hugo Bellen and Konrad Zinsmaier. S.G. was sup-
Tb/Pin88K was generated. The chromosome carrying T(2:3) CyO ported by a fellowship from the Wills Foundation. This work was
TM6B, Tb is referred to as B3 and carries the dominant markers, supported by National Institutes of Health grant GM35252. L.S.B.G.
Hu, Tb, and Cyo. Appl-GAL4/Appl-GAL4;B3/Pin88K females were is an Investigator of the Howard Hughes Medical Institute.
crossed to yw;khc8/Cyo, yw;/;Df(3L)8ex94/TM3, yw;roblK/Cyo, or
yw;/;Df(3L)GN24/TM3 males. Females that were Appl-GAL4/ Received March 9, 2001; revised September 6, 2001.
Appl-GAL4;B3/khc8, Appl-GAL4/Appl-GAL4;B3/Df(3L)8ex94, or Appl-
GAL4/Appl-GAL4;B3/roblk were crossed to males homozygous for
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